US HB2883 | 2021-2022 | 117th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 6-3)
Status: Introduced on April 28 2021 - 25% progression, died in chamber
Action: 2021-09-29 - Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
Text: Latest bill text (Introduced) [PDF]

Summary

To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Stop Stalling Access to Affordable Medications

Sponsors


History

DateChamberAction
2021-09-29HouseOrdered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
2021-09-29HouseCommittee Consideration and Mark-up Session Held.
2021-04-28HouseReferred to the House Committee on the Judiciary.
2021-04-28HouseIntroduced in House

Same As/Similar To

SB1425 (Related) 2021-12-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 179.

Subjects


US Congress State Sources


Bill Comments

feedback